Ozempic/Wegovy has been making headlines lately, popping up in the news for various reasons
However, in contrast to anti-hyperlycemic agents such as metformin, pioglitazone and peroxisome proliferator-activated receptor gamma (PPAR) agonists, which were particularly well studied in this matter, very few clinical studies concerning the effects of GLP-1R targeting therapeutics on alleviation of depressive symptoms in humans have been carried out so far [118, 119]
We also thank Shawn Abbasi for his help with initial authentic virus infections
31 Pre-clinical and human studies have demonstrated the intricate involvement of gut microbiota in the regulation of social behavior, 38,39,40,41,42 depressive-like behavior, 43,44,45,46,47 physical performance, and motivation
Novel, in-vivo and in vitro data suggest that exenatide, a GLP-1 receptor agonist, may represent an ideal therapy for IIH through rapid reduction of CSF secretion at the choroid plexus, lowering ICP in addition to its weight loss properties
available: NOTE: To correct an existing citation or suggest the addition of a new citation to the PPCPs bibliography, please send the complete citation to Dr
